Senolytics Enter Advanced Clinical Trials: Targeting Cellular Senescence for Longevity and Alzheimer's
Senolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targeting senescent "zombie ...
Read More →Senolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targeting senescent "zombie ...
Read More →Neuralink has received FDA Breakthrough Device Designation for its speech restoration BCI technology, aiming to translat...
Read More →GLP-1 medications in 2026 are transforming from weight-loss drugs to essential cardiovascular and renal therapies. With ...
Read More →Moderna and Merck's 5-year follow-up data for the personalized mRNA cancer vaccine intismeran autogene shows a sustained...
Read More →The 2026 Alzheimer's pipeline features 192 clinical trials, highlighted by the FDA approval of subcutaneous Leqembi and ...
Read More →The CRISPR clinical landscape in 2026 has expanded to over 250 active trials, moving beyond sickle cell disease into in ...
Read More →The Dyson AirPurifier Wearable Gen 2 introduces a silent, zero-resistance electrostatic filtration system and a Neural E...
Read More →The Sonos Arc Ultra utilizes AI acoustic beamforming and Wi-Fi sensing to create a precise, object-based Dolby Atmos sur...
Read More →The Framework Phone 2 introduces hot-swappable camera modules, dual hot-swappable batteries, and an expandable core arch...
Read More →The DJI Mavic 4 Pro introduces omnidirectional LiDAR for foolproof obstacle avoidance and a CineAI engine that autonomou...
Read More →The Nothing Phone (3) introduces a dynamic, full-color E-Ink Glyph Matrix on its rear panel and a modular, user-replacea...
Read More →The Garmin Fenix 9 introduces medical-grade, non-invasive glucose and continuous hydration monitoring using advanced opt...
Read More →